Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.
Gil-Guillen VF, Balsa A, Bernárdez B, Valdés Y Llorca C, Márquez-Contreras E, de la Haba-Rodríguez J, Castellano JM, Gómez-Martínez J. Gil-Guillen VF, et al. Among authors: de la haba rodriguez j. Int J Environ Res Public Health. 2022 Sep 23;19(19):12036. doi: 10.3390/ijerph191912036. Int J Environ Res Public Health. 2022. PMID: 36231341 Free PMC article. Review.
A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
Flores-Paco P, Vargas-Aliaga A, Guevara MG, Lopera I, Ruiz LR, López-Herrero M, Camús JA, López-González J, Inga-Saavedra E, Montero M, Barneto I, Gómez-España MA, Ruiz E, Ruza M, Armenta A, Palacios A, De La Haba-Rodríguez JR, Aranda E. Flores-Paco P, et al. Among authors: de la haba rodriguez jr. J Neurooncol. 2024 Mar 27. doi: 10.1007/s11060-024-04618-1. Online ahead of print. J Neurooncol. 2024. PMID: 38539006
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer.
Martín M, González-Rivera M, Morales S, de la Haba-Rodriguez J, González-Cortijo L, Manso L, Albanell J, González-Martín A, González S, Arcusa A, de la Cruz-Merino L, Rojo F, Vidal M, Galván P, Aguirre E, Morales C, Ferree S, Pompilio K, Casas M, Caballero R, Goicoechea U, Carrasco E, Michalopoulos S, Hornberger J, Prat A. Martín M, et al. Curr Med Res Opin. 2015 Jun;31(6):1129-37. doi: 10.1185/03007995.2015.1037730. Epub 2015 Apr 23. Curr Med Res Opin. 2015. PMID: 25851308
Breast cancer screening: another point of view.
de la Haba Rodríguez JR, Chamorro RM, Vidal MJ, Blanch RS, Beltrán LT, Benito MA, Cabezas SG, Carrasco AJ, Aguilar EA. de la Haba Rodríguez JR, et al. Eur J Cancer Prev. 2005 Feb;14(1):1-5. doi: 10.1097/00008469-200502000-00001. Eur J Cancer Prev. 2005. PMID: 15677889
Time-to-progression in breast cancer: a stratification model for clinical trials.
de la Haba-Rodríguez J, Aranda E, Llombart A, Lluch A, Alba E, Munárriz B, Adrover E, Tusquets I, Balil A, Barnadas A, Calvo L, Martín M; Grupo Español de Investigación en Cáncer de Mama (GEICAM). de la Haba-Rodríguez J, et al. Breast. 2008 Jun;17(3):239-44. doi: 10.1016/j.breast.2007.09.007. Epub 2007 Nov 26. Breast. 2008. PMID: 18042386
Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007.
de la Haba-Rodríguez J, Alba E, Barnadas A, Bayo E, Llombart A, Lluch A, Martín M, Moreno-Nogueira JA, Pérez Manga G, Rodríguez-Lescure A, Aranda E. de la Haba-Rodríguez J, et al. Clin Transl Oncol. 2008 Sep;10(9):552-9. doi: 10.1007/s12094-008-0250-y. Clin Transl Oncol. 2008. PMID: 18796372
Impact of breast cancer treatment on fertility.
de la Haba-Rodríguez J, Calderay M. de la Haba-Rodríguez J, et al. Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:59-63. doi: 10.1007/s10549-010-1069-7. Epub 2010 Aug 14. Breast Cancer Res Treat. 2010. PMID: 20711656 No abstract available.
69 results